| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 01/15/2003 | EP1274710A2 Novel heteroaryl-diazabicycloalkanes |
| 01/15/2003 | EP1274701A1 Chemical compounds |
| 01/15/2003 | EP1274464A2 Compositions and methods for regulated protein expression in gut |
| 01/15/2003 | EP1274459A2 Sustained release formulations comprising growth hormone |
| 01/15/2003 | EP1274437A1 Medical combinations comprising tiotropium and fluticasone proprionate |
| 01/15/2003 | EP1274416A1 Dermatological use and a dermatological preparation |
| 01/15/2003 | EP1274409A2 Antiprogestins with partial agonist activity |
| 01/15/2003 | EP1274407A2 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 01/15/2003 | EP0937057B1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 01/15/2003 | EP0907643B1 Compounds with growth hormone releasing properties |
| 01/15/2003 | EP0751769B1 Medical treatment using thyroid hormones |
| 01/15/2003 | EP0584347B1 Enantiomeric hydroxylated xanthine compounds |
| 01/15/2003 | CN1391576A Androgen receptor modulator compounds and methods |
| 01/15/2003 | CN1391464A Formulation for menopausal women |
| 01/15/2003 | CN1098841C Novel amide derivatives and medicinal compositions thereof |
| 01/15/2003 | CN1098684C Orally administerable pharmaceutical formulations |
| 01/14/2003 | US6506912 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 01/14/2003 | US6506874 Hypoglycemic agents; obesity, nervous system, cardiovascular, and kidney disorder treatment |
| 01/14/2003 | US6506762 Certain alkylene diamine-substituted heterocycles |
| 01/14/2003 | US6506753 Anxiolytic agents, anticonvulsants |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002594A1 Hypoglycaemic peptides and methods of use thereof |
| 01/09/2003 | WO2003002569A1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48 |
| 01/09/2003 | WO2003002561A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | WO2003002559A2 Piperidine compounds for use as orexin receptor antagonist |
| 01/09/2003 | WO2003002175A2 Enhanced systemic absorption of intradermally delivered substances |
| 01/09/2003 | WO2003002154A1 Artificial autologous skin secreting leptin and method for obtaining the same |
| 01/09/2003 | WO2003002103A2 Hydrophobic dopamine agonists administered to the dermis |
| 01/09/2003 | WO2003002094A2 Enhanced pharmacokinetic profile of hydrophobic substances |
| 01/09/2003 | WO2003002092A2 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
| 01/09/2003 | WO2003002091A2 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same |
| 01/09/2003 | WO2003002058A2 Bone anabolic compounds and methods of use |
| 01/09/2003 | WO2002079786A9 Method for identifying drugs for the treatment of type ii diabetes |
| 01/09/2003 | WO2002072084A8 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 01/09/2003 | WO2002069994A3 Combined use of derivatives of glp-1 analogs and ppar ligands |
| 01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/09/2003 | WO2002059102A3 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 01/09/2003 | WO2002049622A3 Transdermal system containing a novel high potency progestagen |
| 01/09/2003 | WO2002046373A9 Method of collecting placental stem cells |
| 01/09/2003 | WO2002024726A3 Olfactory and pheromones g-protein coupled receptors |
| 01/09/2003 | WO2002000017A3 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 01/09/2003 | WO2001093848A3 Starter kit for low dose oral contraceptives |
| 01/09/2003 | WO2001079480A9 Albumin fusion proteins |
| 01/09/2003 | WO2001074846A3 Peptides mimicking the biological activity of steroid hormones and their uses |
| 01/09/2003 | WO2001062297A9 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 01/09/2003 | WO2001055336A9 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/09/2003 | US20030009777 Using galanin agonist in the generation of medicament for the treatment of nerve damage |
| 01/09/2003 | US20030008905 Increasing the capacity of insulin providing cells in an animal by administering to animal a dose of at least one Dipeptidyl-peptidase (DP IV) enzyme activity effector |
| 01/09/2003 | US20030008898 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation |
| 01/09/2003 | US20030008876 Can mimic or block the effect of extracellular calcium on a cell surface calcium receptor; for use in therapy |
| 01/09/2003 | US20030008870 Prophylaxis of painful uterine cramps, dysmenorrhea, in women |
| 01/09/2003 | US20030008862 Function as sulfatase and/or blocking estrogen receptors; prophylaxis and therapy |
| 01/09/2003 | US20030008354 Peptide for use in the diagnosis and treatment of parkinson's, cancer and developmental defects |
| 01/09/2003 | US20030007968 Administering bone marrow cells with lymphyocytes removed; then busulfan |
| 01/09/2003 | US20030007958 Mixture of silica, flow control agent and carrier; cyclooxygenase inhibitor, antiinflammatory agents |
| 01/09/2003 | CA2452393A1 Hydrophobic dopamine agonists administered to the dermis |
| 01/09/2003 | CA2452321A1 Enhanced pharmacokinetic profile of hydrophobic substances |
| 01/09/2003 | CA2452082A1 Extracellular messengers |
| 01/09/2003 | CA2452069A1 Hypoglycaemic peptides and methods of use thereof |
| 01/09/2003 | CA2451464A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | CA2450356A1 Bone anabolic compounds and methods of use |
| 01/09/2003 | CA2450354A1 Enhanced systemic absorption of intradermally delivered substances |
| 01/08/2003 | EP1273590A2 Estra- 1,3,5(10)-triene Derivatives, Methods of Preparing Such Compounds and Pharmaceutical Compositions Containing Them |
| 01/08/2003 | EP1273580A1 Sulfonyl heteroaryl triazoles as anti-inflammatory and analgesic agents |
| 01/08/2003 | EP1273576A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/08/2003 | EP1272852A1 Tpst-assay for diagnosis of autism and related disorders |
| 01/08/2003 | EP1272638A2 Drug metabolizing enzymes |
| 01/08/2003 | EP1272520A2 Gpcr-proteins and nucleic acids encoding same |
| 01/08/2003 | EP1272516A2 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 01/08/2003 | EP1272511A2 Molecules associated with human reproduction |
| 01/08/2003 | EP1272505A1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 01/08/2003 | EP1272504A1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/08/2003 | EP1272481A1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 01/08/2003 | EP1272471A1 Non-steroidal, tetracyclic compounds for estrogen-related treatments |
| 01/08/2003 | EP1272470A1 Amorphous torasemide modification |
| 01/08/2003 | EP1272468A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 01/08/2003 | EP1272206A1 Non-mammalian gnrh analogs and uses thereof in tumor cell growth regulation and cancer therapy |
| 01/08/2003 | EP1272196A2 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha,11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 01/08/2003 | EP1272186A1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 01/08/2003 | EP0728194B1 In situ modification and manipulation of stem cells of the central nervous system |
| 01/08/2003 | CN1390219A Pyrazolopyrimidines as therapeutic agents |
| 01/08/2003 | CN1390131A Use of peptide |
| 01/08/2003 | CN1098266C Fused pyrrolo (2,3-c) carbazole-6-one which potentiate activity of gamma interferon |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098095C Medicine for treating thyropathy |
| 01/07/2003 | US6503939 Combination regimens using 3,3-substituted indoline derivatives |
| 01/07/2003 | US6503895 Antigestagenically active steroids with a fluorinated 17α-alkyl chain |
| 01/07/2003 | US6503894 Pharmaceutical composition and method for treating hypogonadism |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/05/2003 | CA2390181A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000692A2 Oxytocin agonists |
| 01/03/2003 | WO2003000671A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000282A1 Sustained release formulation |
| 01/03/2003 | WO2003000250A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 01/03/2003 | WO2003000249A1 Function regulator for retinoid relative receptor |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |